ORAL Surveillance Author Interview - Roy Fleischmann

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.

Author Interview: Professor Kevin Winthrop (January 2022)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Discussing Rheumatology: HZ and ILD with tofacitinib in RA

Prof Iain McInnes reviews two papers this month, and discusses the risk of herpes zoster (HZ) events in patients with RA treated with tofacitinib, as well as interstitial lung disease, an extra-articular manifestation of RA.

Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA

Prof Iain McInnes reviews two papers this month, and discusses exposure-adjusted incidence rates of TEAEs and AESIs with filgotinib, as well as the efficacy and safety of tofacitinib in pJIA.

Author Interview: Professor Kevin Winthrop (December 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

Author Interview: Professor Kevin Winthrop (November 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.